| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From the Department of Cardiovascular Medicine (M.A.M., J.E.S., S.N., K.M.C., R.P.C.) and University Laboratory of Physiology (K.C.), University of Oxford, United Kingdom.
Correspondence to Dr Robin Choudhury, Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford OX3 9DU. E-mail robin.choudhury{at}cardiov.ox.ac.uk
| Abstract |
|---|
|
|
|---|
Methods and Results Aortic root and brachiocephalic arteries of apolipoprotein E knockout (apoE/) mice fed Western diet for 10, 20, or 30 weeks were imaged ex vivo (11.7 T; 3D multiecho sequence; resolution 47x47x62.5 µm). Using semiautomated histogram-based methods, MRI accurately quantified lipid-rich/necrotic areas in the aortic root (r2=0.84; P<0.001) and brachiocephalic artery (r2=0.90; P<0.001) compared with histology. Similarly, cell-rich caps in aortic roots, quantified by MRI and histology, correlated closely (r2=0.74; P<0.001). Reconstruction of segmented brachiocephalic arteries in 3D provided unique insights into plaque microanatomy and enabled volumetric quantification of plaque and lipid-rich/necrotic core. Between 10 and 30 weeks, 3D measurement identified an 11.6-fold increase in plaque volume (versus 4.1-fold for 2D) and a 21.3-fold increase in plaque lipid-rich/necrotic core volume (versus 6.4-fold for 2D), indicating superior power of 3D quantification.
Conclusions Ex-vivo high-resolution 3D MRI accurately quantified lipid-rich/necrotic core and cell-rich cap areas in atherosclerotic lesions in apoE/ mice. Reconstruction and volumetric quantification of segmented brachiocephalic arteries demonstrated greater sensitivity in detecting changes in plaque size and lipid composition over time than 2D analysis.
We tested the ability of high-resolution MRI to quantify mouse atherosclerotic plaque components ex vivo. MRI accurately quantified lipid-rich/necrotic core and cell-rich cap components, as confirmed by histopathology. Three-dimensional reconstruction of brachiocephalic arteries enabled more sensitive volumetric quantification of differences in plaque and lipid-rich/necrotic cores than 2D analysis.
Key Words: atherosclerosis brachiocephalic artery apoE/ mice MRI lipid-rich/necrotic core
| Introduction |
|---|
|
|
|---|
500 µm external diameter). Furthermore, preparation and processing for histology introduces size distortion during tissue dehydration and has the potential to disrupt the integrity of the plaque itself. Using multicontrast MRI (T1-weighted [T1W], T2W, proton density-weighted [PDW]) with submillimeter spatial resolution, plaque components have been distinguished without tissue destruction in carotid artery specimens ex vivo1214 and in human carotid artery15 and aorta16 in vivo. Magnetic resonance (MR) has also been shown to discriminate atherosclerotic plaque components in larger animal models including rabbits,1719 pigs,20 and nonhuman primates.21
In apoE/ mice, MRI accurately quantifies atherosclerosis in the abdominal aorta,22 aortic arch,23 aortic root,24 and brachiocephalic artery25 in vivo. However, genetic and pharmacological interventions affect not only plaque size but also composition.26 Therefore, plaque quantification alone does not fully capitalize on the power of MRI as a phenotyping tool in atherosclerosis. Itskovich et al24 first demonstrated the potential of ex vivo MRI for characterization of mouse aortic root plaque, but no study has systematically evaluated this with histological validation, nor have lesions been examined in the brachiocephalic artery, where recent studies suggest that characterization is more important.8,9
Accordingly, we developed a high-resolution 3D MRI method for analysis of atherosclerotic plaques in apoE/ mice ex vivo. We tested the ability of 3D MRI to quantify lipid-rich/necrotic cores and cell-rich caps in aortic roots and brachiocephalic arteries and to determine changes in composition in plaques of varying complexity.
| Methods |
|---|
|
|
|---|
Ex Vivo Sample Preparation
After each feeding period, mice were deeply anesthetized by inhalation of isofluorane. Hearts and aortas were perfused in situ with PBS followed by 4% paraformaldehyde in PBS via the left ventricle. Perivascular tissue was removed from the aortic arch and its branches. The aortic tree and heart, attached to the spinal column, was removed en bloc and embedded in a glass MR tube containing 2% agarose. Fomblin, a liquid hydrocarbon (Ausimont), was instilled via the left ventricle and the tube sealed with a second layer of agarose to secure tissue preparation during imaging.
Ex Vivo MRI
Ex vivo MRI was performed using an 11.7-T (500 MHz) vertical magnet (Bruker) and a 13-mm 1H birdcage radiofrequency coil (RAPID Biomedical). Four echoes were acquired using a 3D multiecho sequence (
-echo time 7 ms; repetition time 200 ms; number of averaged experiments 4; total experimental time
7 hours performed overnight, unattended). A field of view of 12x12x8 mm and a matrix size of 256x256x128 led to a voxel size of 47x47x62.5 µm before zero filling. MR data were acquired and reconstructed to generate a stack of 2D tiff images (16 bit) using purpose-written software.
Histological Processing of the Aortic Root and Brachiocephalic Artery
After imaging, the heart was removed from each specimen and transected at the level of the atria. The brachiocephalic artery was also dissected from the aortic arch to the bifurcation into right carotid and subclavian arteries. Specimens were dehydrated through graded ethanol solutions and Neo-clear (VWR International), paraffin-embedded, and serially sectioned (5-µm thick). Sections of aortic root and brachiocephalic artery (spaced
80 µm apart; 3 sections per mouse per site) were rehydrated and stained with a combined Elastic kit (Sigma) to stain elastic laminae and nuclei black, and Massons Trichrome (VWR International) to stain collagen green, cells red, and erythrocytes orange.28 Lipid within plaques, which dissolved out during tissue processing, appeared as white voids in histological sections.29 Digital light microscopy (LM) images of histological sections were captured with a Cool Snap Pro color video camera (Media Cybernetics) mounted on a light microscope (Leica) using ImagePro Plus image analysis software (version 4.5.1; Media Cybernetics).
Two-Dimensional MRI Segmentation and Quantification
Two-dimensional MR images and corresponding histopathologic sections were matched using surrounding anatomic structures, such as the atria and right ventricular outflow tract for the aortic root, whereas for the brachiocephalic artery, the origin at the aortic arch and the right carotid/subclavian bifurcation were used as fiducial references. Plaque area was quantified by manual tracing with ImagePro Plus. Lipid-rich/necrotic core and cell-rich cap areas were segmented and quantified using a semiautomated, histogram-based threshold method.
Three-Dimensional Reconstruction and Volumetric Quantification of Brachiocephalic Artery Plaque
MR image stacks for the entire brachiocephalic artery and its segmented plaque and segmented lipid-rich/necrotic core "masks" were assigned to red, blue, and green color channels, respectively, and reconstructed in 3D using the 3D Constructor plug-in for ImagePro Plus. Isosurfaces for the color channels corresponding to plaque and lipid-rich/necrotic cores were added and the enclosed volumes quantified.
Statistical Analyses
Correlations of measurements by MRI and histopathology were tested by linear regression analysis using Prism software version 3.02 (GraphPad). BlandAltman plots30 were constructed to determine the level of agreement between MRI and LM measurements. Intraobserver and interobserver coefficients of variation (CVs) for plaque lipid-rich/necrotic core and cell-rich cap areas were calculated by analyzing random MR images (n=15). Differences in area and volume measurements for each parameter between 10, 20, and 30 weeks were determined using Student t test. Statistical significance was attributed to P values <0.05.
| Results |
|---|
|
|
|---|
|
Two-Dimensional Segmentation of Plaque Components and Correlation With Histopathology
MRI showed excellent correlation with histopathology for quantification of plaque area in the aortic root (r2=0.90; P<0.0001) and brachiocephalic artery (r2=0.90; P<0.0001). Areas of atherosclerotic plaque showed MR signal heterogeneity. Based on anatomic distribution, we tested the hypothesis that low signal (black and dark gray) areas within the plaque represented lipid-rich/necrotic cores, whereas high signal (light gray) areas reflected cell-rich cap regions. These areas were segmented using a semiautomated histogram-based approach. Figure 2 shows a typical signal intensity histogram derived from an MR image of a brachiocephalic artery from an apoE/ mouse fed Western diet for 20 weeks. Three peaks were identified on the histogram, representing black, dark gray, and light gray regions in the MR image. Accordingly, within the arterial wall, the number of pixels comprising the first 2 peaks was quantified as lipid-rich/necrotic core, whereas pixels comprising the light gray peak were taken to be cell-rich areas. Using this approach, we found excellent correlation between MRI and histological measurements for lipid-rich/necrotic core areas in aortic root (r2=0.84; P<0.0001) and in brachiocephalic artery plaques (r2=0.80; P<0.0001). Quantification of cell-rich areas present in the caps of aortic root lesions by MRI also correlated well with histopathology measurements (r2=0.74; P<0.0001).Cell-rich caps were not quantified in brachiocephalic arteries because they were not typically present in these lesions at the time points studied.
|
Agreement and Reproducibility of MRI Data
BlandAltman plots for testing agreement of MRI and histopathology measurements of plaque, lipid-rich/necrotic core, and cell-rich cap areas in the aortic root and brachiocephalic artery are shown in supplemental Figure II (available online at http://atvb.ahajournals.org) and Figure 3, respectively. Overall agreement between the 2 methods was excellent. For aortic root and brachiocephalic artery plaque areas, 89 (94%) and 73 (100%) fell within one (two) SD of the mean difference, respectively. Similar values were obtained for lipid-rich/necrotic core areas (82 [94%] and 81 [92%], respectively) and for aortic root cell-rich cap areas (83 [96%]).
|
For MRI, intraobserver CVs for aortic root and brachiocephalic artery plaque areas (8.2% and 7.0%, respectively) and lipid-rich/necrotic core areas (12.7% and 10.1%, respectively) were reproducible. Interobserver assessment also demonstrated similar reproducibility (plaque area 13.1%; lipid-rich/necrotic core area 10.0%). Cell-rich cap area measurements by MRI gave good intraobserver and interobserver agreement (10.4% and 17.2%, respectively). One value for cell-rich caps was excluded from the interobserver readings because the valve cusp, which also appeared as a bright signal on the MR image, was misinterpreted by an observer as a cell-rich cap.
Three-Dimensional Reconstruction and Volumetric Quantification of Brachiocephalic Artery Plaque and Lipid-Rich/Necrotic Cores
To establish the distribution of lipid-rich/necrotic cores within the plaque and their variation with increasing plaque complexity, segmented images of the brachiocephalic artery were reconstructed in 3D. Figure 4 shows typical 3D-reconstructed and surface-rendered image stacks of segmented plaque and lipid-rich/necrotic cores in the brachiocephalic artery of an apoE/ mouse fed Western diet for 20 weeks. To determine the sensitivity of 3D MRI in detecting changes in the plaque size and composition, plaque and lipid-rich/necrotic core volumes were quantified and compared with their respective 2D area measurements (Table). Three-dimensional volumetric measurements were more sensitive than 2D area quantification in detecting plaque progression over time (6.8-fold versus 2.9-fold between 10 and 20 weeks; 1.7-fold versus 1.4-fold between 20 and 30 weeks; 11.6-fold versus 4.1-fold between 10 and 30 weeks, respectively). Lipid-rich/necrotic core volume also increased significantly between 10 and 20 weeks but not thereafter. Volumetric 3D quantification of lipid-rich/necrotic cores again detected greater increases than 2D area measurements (12.0-fold versus 4.7-fold between 10 and 20 weeks and 21.3-fold versus 6.4-fold between 10 and 30 weeks, respectively). The proportion of plaque occupied by lipid-rich/necrotic cores significantly increased from 5% to 22% between 10 and 20 weeks (P<0.01) but did not increase further between 20 and 30 weeks.
|
|
Volumetric analysis identified differences in plaque distribution through the brachiocephalic artery with time. At 10 weeks, the majority of plaque and lipid-rich/necrotic core volumes were localized in the proximal half of the artery (88% and 91%, respectively). Plaque and lipid-rich/necrotic core volumes in all mice appeared to extend progressively in a continuous fashion along the right (but not the left) side of the artery, starting at the junction with the aortic arch and extending distally in continuity with the existing lesion rather than in random or isolated regions. At 20 and 30 weeks, 47% and 54% plaque volume and 52% and 52% lipid-rich/necrotic volume, respectively, were in the proximal half of the artery.
| Discussion |
|---|
|
|
|---|
Itskovich et al24 first demonstrated the potential of ex vivo MRI to characterize lipid and fibrous plaque components in murine atherosclerotic lesions in the aortic root. With in-plane resolution of 50 µm/pixel (slice thickness 300 µm), areas of heterogeneity in T1W, T2W, and PDW images of aortic root were proposed to represent lipid cores and fibrous caps in corresponding histopathologic sections. To build on this previous work, significant improvements in MR spatial resolution have been achieved using a 3D rather than a 2D acquisition matrix (256x256x128) that led to near-isotropic voxel size of 47x47x62.5 µm3 (23.5x23.5x31.8 µm3 after interpolation). The significantly longer imaging time (7 hours) was efficiently accommodated by running unsupervised overnight scans.
In earlier systematic evaluation, we found that summation of T2W images combining multiple echo images obtained within the same experiment provided optimal tissue contrast.30a Images generated in this way showed excellent agreement with histopathology. BlandAltman tests of agreement between MRI and histopathology data showed systematically higher measurements of plaque areas and its components by MRI. This represents a distortion in tissue prepared for histology. For example, increasing cell cap area was associated with a progressive increase in the discrepancy between the cap area measured by MRI and by LM. During tissue processing for histology, water-rich tissues shrink because of dehydration. In contrast, MRI measurements, made on nonprocessed tissue, more closely reflected tissue architecture in vivo. An incremental pattern resulted because the effects of dehydration became increasingly prominent with increasing cellular (water-rich) content. Similar effects have been noted previously.24,31 Consistent with this, a similar error increment was not observed in the measurement of lipid-rich/necrotic area using the 2 techniques.
Histological processing may introduce further artifacts. The brachiocephalic artery is small, fragile, and difficult to manipulate. In some instances, vessel disruption that was apparent during histology was not seen on the corresponding previous MR images (Figure 1). This may indicate damage to this vulnerable vessel segment during preparation and sectioning and further cautions on histological analysis of plaque Micro-anatomy.
Three-dimensional reconstruction of segmented brachiocephalic artery images enabled us to examine, for the first time, changes in plaque distribution throughout the entire artery, with time. Previously, plaque progression in the brachiocephalic artery has been investigated in 2D histological sections,8,9,11 which provide valuable information on plaque morphology but cannot fully interrogate plaque distribution in relation to the entire artery. Our observation from 3D-reconstructed images that only the right side of the brachiocephalic artery was affected during plaque progression may have implications for mechanisms of atherogenesis, including flow dynamics, and may focus attention on these regions in future studies.
Clearly, in vivo plaque characterization in mice is a desirable goal but has not yet been accomplished. Previous in vivo studies have shown high resolution in plane (109x109 µm), but slice thickness (500 µm) led to disabling partial volume effects.16,32,33 Furthermore, anisotropic voxels preclude the type of 3D reconstruction and analyses performed in the current study. Hockings et al used a 3D technique (7-T) for in vivo imaging in mice but with significantly larger voxels (187x187x140 µm) than reported here.25 Prolonged imaging protocols of the sort described here are not feasible in vivo; therefore, we anticipate that further advances in microscopic plaque characterization will require new contrast agents.34,35 Gadolinium-conjugated nanoparticles that are targeted to specific molecules have been used to image thrombus36 and integrins37 in larger animals. Such imaging in mice is keenly anticipated and will greatly enhance in vivo studies by introducing the possibility for functional and serial imaging. However, molecular imaging is unlikely to match the detailed, very high resolution information on plaque composition achieved with ex vivo MRI.
Lesions in the brachiocephalic artery of mice often possess a large lipid-rich/necrotic core and thin fibrous cap, and these types of lesion are particularly well suited to analyses of plaque composition, which assess plaque responses to pharmacological3841 and genetic42,43 interventions in mice. Ex vivo MRI provides a means to accurately and efficiently quantify plaque and its components in small numbers of mice without need for histology. With minor methodological modification to the embedding process, it would be possible to image multiple arteries simultaneously, analogous to the method described for imaging mouse fetuses, thus presenting the possibility for high-throughput phenotyping.44 Importantly, the technique is tissue nondestructive, and imaged tissue can be recovered for subsequent histological or immunohistochemical analysis if required.
| Conclusions |
|---|
|
|
|---|
| Acknowledgments |
|---|
Received June 11, 2004; accepted August 26, 2004.
| References |
|---|
|
|
|---|
2. Plump A. Atherosclerosis and the mouse: a decade of experience. Ann Med. 1997; 29: 193198.[Medline] [Order article via Infotrieve]
3. Bennett MR. Breaking the plaque: evidence for plaque rupture in animal models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2002; 22: 713714.
4. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994; 14: 133140.
5. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987; 68: 231240.[CrossRef][Medline] [Order article via Infotrieve]
6. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995; 92: 13551374.
7. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol. 2002; 15: 439446.[Medline] [Order article via Infotrieve]
8. Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol. 2000; 20: 25872592.
9. Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis. 2001; 154: 399406.[CrossRef][Medline] [Order article via Infotrieve]
10. Calara F, Silvestre M, Casanada F, Yuan N, Napoli C, Palinski W. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol. 2001; 195: 257263.[CrossRef][Medline] [Order article via Infotrieve]
11. Williams H, Johnson JL, Carson KG, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2002; 22: 788792.
12. Coombs BD, Rapp JH, Ursell PC, Reilly LM, Saloner D. Structure of plaque at carotid bifurcation: high-resolution MRI with histological correlation. Stroke. 2001; 32: 25162521.
13. Shinnar M, Fallon JT, Wehrli S, Levin M, Dalmacy D, Fayad ZA, Badimon JJ, Harrington M, Harrington E, Fuster V. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol. 1999; 19: 27562761.
14. Toussaint JF, Southern JF, Fuster V, Kantor HL. T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol. 1995; 15: 15331542.
15. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation. 2000; 102: 959964.
16. Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, Badimon JJ, Charlton SA, Fisher EA, Breslow JL, Fuster V. Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 1998; 98: 15411547.
17. Skinner MP, Yuan C, Mitsumori L, Hayes CE, Raines EW, Nelson JA, Ross R. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med. 1995; 1: 6973.[CrossRef][Medline] [Order article via Infotrieve]
18. Ford JC, Shlansky-Goldberg RD, Golden M. MR microscopy of the arterial wall in an experimental model of atherosclerosis: preliminary results. J Vasc Interv Radiol. 1997; 8: 9399.[Medline] [Order article via Infotrieve]
19. Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman AG, Corti R, Fallon JT, Badimon JJ. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation. 2002; 105: 993998.
20. Worthley SG, Helft G, Fuster V, Fayad ZA, Fallon JT, Osende JI, Roque M, Shinnar M, Zaman AG, Rodriguez OJ, Verhallen P, Badimon JJ. High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis. 2000; 150: 321329.[CrossRef][Medline] [Order article via Infotrieve]
21. Kaneko E, Yuan C, Skinner MP, Raines EW, Ross R. Serial magnetic resonance imaging of experimental atherosclerosis allows visualization of lesion characteristics and lesion progression in vivo. Ann N Y Acad Sci. 1997; 811: 245252.[Medline] [Order article via Infotrieve]
22. Fayad ZA. MR imaging for the noninvasive assessment of atherothrombotic plaques. Magn Reson Imaging Clin N Am. 2003; 11: 101113.[CrossRef][Medline] [Order article via Infotrieve]
23. Wiesmann F, Szimtenings M, Frydrychowicz A, Illinger R, Hunecke A, Rommel E, Neubauer S, Haase A. High-resolution MRI with cardiac and respiratory gating allows for accurate in vivo atherosclerotic plaque visualization in the murine aortic arch. Magn Reson Med. 2003; 50: 6974.[CrossRef][Medline] [Order article via Infotrieve]
24. Itskovich VV, Choudhury RP, Aguinaldo JG, Fallon JT, Omerhodzic S, Fisher EA, Fayad ZA. Characterization of aortic root atherosclerosis in ApoE knockout mice: High-resolution in vivo and ex vivo MRM with histological correlation. Magn Reson Med. 2003; 49: 381385.[CrossRef][Medline] [Order article via Infotrieve]
25. Hockings PD, Roberts T, Galloway GJ, Reid DG, Harris DA, Vidgeon-Hart M, Groot PH, Suckling KE, Benson GM. Repeated three-dimensional magnetic resonance imaging of atherosclerosis development in innominate arteries of low-density lipoprotein receptor-knockout mice. Circulation. 2002; 106: 17161721.
26. Virmani R, Burke AP, Kolodgie FD, Farb A. Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol. 2003; 16: 267272.
27. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Jr., Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, Am Heart Association. Circulation. 1994; 89: 24622478.
28. Garvey W. Modified elastic tissue-Masson trichrome stain. Stain Technol. 1984; 59: 213216.[Medline] [Order article via Infotrieve]
29. Mitchinson MJ. Insoluble lipids in human atherosclerotic plaques. Atherosclerosis. 1982; 45: 1115.[CrossRef][Medline] [Order article via Infotrieve]
30. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1: 307310.[CrossRef][Medline] [Order article via Infotrieve]
30. Schneider JE, McAteer MA, Tyler DJ, Clarke K, Channon KM, Choudhury RP, Neubauer S. High-resolution, multi-contrast 3D MRI characterizes atherosclerotic plaque composition in apoE/ mice ex vivo. J Magn Reson Imaging. In press.
31. Choudhury RP, Aguinaldo JG, Rong JX, Kulak JL, Kulak AR, Reis ED, Fallon JT, Fuster V, Fisher EA, Fayad ZA. Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy. Atherosclerosis. 2002; 162: 315321.[CrossRef][Medline] [Order article via Infotrieve]
32. Choudhury RP, Fayad ZA, Aguinaldo JG, Itskovich VV, Rong JX, Fallon JT, Fisher EA. Serial, noninvasive, in vivo magnetic resonance microscopy detects the development of atherosclerosis in apolipoprotein E-deficient mice and its progression by arterial wall remodeling. J Magn Reson Imaging. 2003; 17: 184189.[CrossRef][Medline] [Order article via Infotrieve]
33. Choudhury RP, Fuster V, Badimon JJ, Fisher EA, Fayad ZA. MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol. 2002; 22: 10651074.
34. Barkhausen J, Ebert W, Heyer C, Debatin JF, Weinmann HJ. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging. Circulation. 2003; 108: 605609.
35. Sirol M, Itskovich VV, Mani V, Aguinaldo JG, Weinmann HJ, Toussaint JF, Fuster V, Fayad ZA. A new method for plaque detection using novel MR contrast agent in vivo. J Cardiov Magn Reson. 2004; 6: 368369.
36. Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, Lanza GM. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation. 2001; 104: 12801285.
37. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA. Molecular imaging of angiogenesis in early-stage atherosclerosis with
(v)ß3-integrin-targeted nanoparticles. Circulation. 2003; 108: 22702274.
38. Bea F, Blessing E, Bennett B, Levitz M, Wallace EP, Rosenfeld ME. Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering. Arterioscler Thromb Vasc Biol. 2002; 22: 18321837.
39. Shah PK, Yano J, Reyes O, Chyu KY, Kaul S, Bisgaier CL, Drake S, Cercek B. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation. 2001; 103: 30473050.
40. Shah PK, Nilsson J, Kaul S, Fishbein MC, Ageland H, Hamsten A, Johansson J, Karpe F, Cercek B. Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice. Circulation. 1998; 97: 780785.
41. Kusunoki J, Hansoty DK, Aragane K, Fallon JT, Badimon JJ, Fisher EA. Acyl-CoA: cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2001; 103: 26042609.
42. Rong JX, Li J, Reis ED, Choudhury RP, Dansky HM, Elmalem VI, Fallon JT, Breslow JL, Fisher EA. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation. 2001; 104: 24472452.
43. Reis ED, Li J, Fayad ZA, Rong JX, Hansoty D, Aguinaldo JG, Fallon JT, Fisher EA. Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J Vasc Surg. 2001; 34: 541547.[CrossRef][Medline] [Order article via Infotrieve]
44. Matsuda Y, Utsuzawa S, Kurimoto T, Haishi T, Yamazaki Y, Kose K, Anno I, Marutani M. Super-parallel MR microscope. Magn Reson Med. 2003; 50: 183189.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
J. Gronros, J. Wikstrom, U. Brandt-Eliasson, G. B. Forsberg, M. Behrendt, G. I. Hansson, and L. M. Gan Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2046 - H2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. McAteer, J. E. Schneider, Z. A. Ali, N. Warrick, C. A. Bursill, C. von zur Muhlen, D. R. Greaves, S. Neubauer, K. M. Channon, and R. P. Choudhury Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Jackson Defining and Defending Murine Models of Plaque Rupture Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 973 - 977. [Full Text] [PDF] |
||||
![]() |
C. L. Jackson, M. R. Bennett, E. A.L. Biessen, J. L. Johnson, and R. Krams Assessment of Unstable Atherosclerosis in Mice Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 714 - 720. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |